Four-year outcomes with third-generation centrifugal left ventricular assist devices in an era of restricted transplantation

OBJECTIVES: Third-generation ventricular assist devices (VADs) are associated with improved outcomes, though in recent clinical trials bridge-to-transplant (BTT) rates are ∼30% at 6 months, so that transplantation can be used as a ‘bail out’ for serious complications. In the UK, there was a signific...

Descripción completa

Detalles Bibliográficos
Autores principales: Özalp, Faruk, Bhagra, Sai, Bhagra, Catriona, Butt, Tanveer, Ramesh, Bandigowdanapalya, Robinson-Smith, Nicola, Wrightson, Neil, Parry, Gareth, Griselli, Massimo, Hasan, Asif, Schueler, Stephan, MacGowan, Guy A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2014
Materias:
Transplantation and Mechanical Circulatory Support
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128784/
https://www.ncbi.nlm.nih.gov/pubmed/24980558
http://dx.doi.org/10.1093/ejcts/ezu258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128784/
https://www.ncbi.nlm.nih.gov/pubmed/24980558
http://dx.doi.org/10.1093/ejcts/ezu258

Ejemplares similares